International Journal of Biological Macromolecules, Год журнала: 2025, Номер 310, С. 142914 - 142914
Опубликована: Апрель 25, 2025
Язык: Английский
International Journal of Biological Macromolecules, Год журнала: 2025, Номер 310, С. 142914 - 142914
Опубликована: Апрель 25, 2025
Язык: Английский
BioMedical Engineering OnLine, Год журнала: 2025, Номер 24(1)
Опубликована: Фев. 7, 2025
Articular cartilage injury is a serious bone disease that can result in disabilities. With the rapid increase aging population, this disorder has become an increasingly important public health issue. Recently, stem cell-based tissue engineering emerged as promising therapeutic option for treating articular damage. Cellular scaffolds, which are among three key elements of engineering, play significant roles repair damaged by regulating cellular responses and promoting regeneration. Biological macromolecules commonly used scaffold materials owing to their unique properties. For example, natural synthetic polymer hydrogel scaffolds effectively mimic microenvironment extracellular matrix; exhibit high cytocompatibility, biocompatibility, biodegradability; have attracted increasing attention regeneration medicine. Several types been fabricated treat abnormalities. This article outlines recent progress field manufactured from various biomaterials repairing cartilage, discusses advantages disadvantages, proposes directions future development.
Язык: Английский
Процитировано
2Materials Today Bio, Год журнала: 2025, Номер 31, С. 101496 - 101496
Опубликована: Янв. 25, 2025
Язык: Английский
Процитировано
0Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 160665 - 160665
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Colloids and Surfaces B Biointerfaces, Год журнала: 2025, Номер 251, С. 114615 - 114615
Опубликована: Март 7, 2025
Язык: Английский
Процитировано
0Molecular Neurobiology, Год журнала: 2025, Номер unknown
Опубликована: Март 17, 2025
Abstract Neurodegenerative diseases (NDs) like Alzheimer’s, Parkinson’s, and ALS rank among the most challenging global health issues, marked by substantial obstacles in early diagnosis effective treatment. Current diagnostic techniques frequently demonstrate inadequate sensitivity specificity, whilst conventional treatment strategies encounter challenges related to restricted bioavailability insufficient blood–brain barrier (BBB) permeability. Recently, exosomes—nanoscale vesicles packed with proteins, RNAs, lipids—have emerged as promising agents potential reshape therapeutic approaches these diseases. Unlike drug carriers, they naturally traverse BBB can deliver bioactive molecules affected neural cells. Their molecular cargo influence cell signaling, reduce neuroinflammation, potentially slow neurodegenerative progression. Moreover, exosomes serve non-invasive biomarkers, enabling precise while allowing real-time disease monitoring. Additionally, engineered exosomes, loaded molecules, enhance this capability targeting diseased neurons overcoming barriers. By offering enhanced reduced immunogenicity, an ability bypass physiological limitations, exosome-based present a transformative advantage over existing approaches. This review examines multifaceted role of NDDs, emphasizing their capabilities, intrinsic functions, advanced vehicles.
Язык: Английский
Процитировано
0International Journal of Biological Macromolecules, Год журнала: 2025, Номер unknown, С. 142271 - 142271
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0International Journal of Biological Macromolecules, Год журнала: 2025, Номер 310, С. 142914 - 142914
Опубликована: Апрель 25, 2025
Язык: Английский
Процитировано
0